UY34170A - Crystalline forms of 2,2,2-trifluoro-N - [(1R, 2S) -1- [1- (4-fluorophenyl) indazol-5-yl] oxy-1- (3-methoxyphenyl) propan-2-yl ] acetamide - Google Patents

Crystalline forms of 2,2,2-trifluoro-N - [(1R, 2S) -1- [1- (4-fluorophenyl) indazol-5-yl] oxy-1- (3-methoxyphenyl) propan-2-yl ] acetamide

Info

Publication number
UY34170A
UY34170A UY0001034170A UY34170A UY34170A UY 34170 A UY34170 A UY 34170A UY 0001034170 A UY0001034170 A UY 0001034170A UY 34170 A UY34170 A UY 34170A UY 34170 A UY34170 A UY 34170A
Authority
UY
Uruguay
Prior art keywords
indazol
propan
trifluoro
acetamide
fluorophenyl
Prior art date
Application number
UY0001034170A
Other languages
Spanish (es)
Inventor
Helena Ingemo Andersson
Kelly Yvonne Conway
Michael John Quayle
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY34170A publication Critical patent/UY34170A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Escanear Compuesto I pág. 8/70 SGDD
UY0001034170A 2011-06-29 2012-06-28 Crystalline forms of 2,2,2-trifluoro-N - [(1R, 2S) -1- [1- (4-fluorophenyl) indazol-5-yl] oxy-1- (3-methoxyphenyl) propan-2-yl ] acetamide UY34170A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161502656P 2011-06-29 2011-06-29

Publications (1)

Publication Number Publication Date
UY34170A true UY34170A (en) 2013-01-31

Family

ID=46420454

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034170A UY34170A (en) 2011-06-29 2012-06-28 Crystalline forms of 2,2,2-trifluoro-N - [(1R, 2S) -1- [1- (4-fluorophenyl) indazol-5-yl] oxy-1- (3-methoxyphenyl) propan-2-yl ] acetamide

Country Status (16)

Country Link
EP (1) EP2726464A1 (en)
JP (1) JP2014527955A (en)
KR (1) KR20140036230A (en)
CN (1) CN103814015A (en)
AR (1) AR086818A1 (en)
AU (1) AU2012277514A1 (en)
BR (1) BR112013031759A2 (en)
CA (1) CA2839398A1 (en)
IN (1) IN2014MN00023A (en)
MX (1) MX2013014566A (en)
RU (1) RU2013153466A (en)
SG (1) SG195309A1 (en)
TW (1) TW201305115A (en)
UY (1) UY34170A (en)
WO (1) WO2013001294A1 (en)
ZA (1) ZA201309480B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017161518A1 (en) 2016-03-23 2017-09-28 Astrazeneca Ab New physical form
CN108314670B (en) * 2018-02-06 2020-04-07 江苏八巨药业有限公司 Preparation method of (S) -2-chloro-1- (6-fluoro-1-chroman-2-yl) -ethanol
WO2022114105A1 (en) * 2020-11-27 2022-06-02 ミライラボバイオサイエンス株式会社 HIGH-PURITY β-NICOTINAMIDE MONONUCLEOTIDE (NMN) AND METHOD FOR PRODUCING SAME
KR102571432B1 (en) * 2023-02-08 2023-08-29 주식회사 에스씨엘테라퓨틱스 Composition for treating cancer containing indazolyl ester and amide derivative

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9101090D0 (en) 1991-04-11 1991-04-11 Astra Ab PROCESS FOR CONDITIONING OF WATER-SOLUBLE SUBSTANCES
SE9302777D0 (en) 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
GB0315509D0 (en) 2003-07-02 2003-08-06 Meridica Ltd Dispensing device
JO2754B1 (en) 2006-12-21 2014-03-15 استرازينكا ايه بي Indazolyl amide derivatives for the treatment of glucocorticoid receptor mediated disorders
WO2008079073A1 (en) 2006-12-22 2008-07-03 Astrazeneca Ab Indazolyl sulphonamide derivatives for the treatment of glucocorticoid receptor mediated disorders
MX2013000687A (en) 2010-07-21 2013-01-29 Astrazeneca Ab Inhaler.
EP2595683B1 (en) 2010-07-21 2015-03-04 AstraZeneca AB Inhaler

Also Published As

Publication number Publication date
TW201305115A (en) 2013-02-01
RU2013153466A (en) 2015-08-10
ZA201309480B (en) 2015-10-28
WO2013001294A1 (en) 2013-01-03
CA2839398A1 (en) 2013-01-03
EP2726464A1 (en) 2014-05-07
SG195309A1 (en) 2013-12-30
AR086818A1 (en) 2014-01-22
MX2013014566A (en) 2014-09-25
IN2014MN00023A (en) 2015-06-12
JP2014527955A (en) 2014-10-23
BR112013031759A2 (en) 2016-12-13
AU2012277514A1 (en) 2014-01-09
CN103814015A (en) 2014-05-21
KR20140036230A (en) 2014-03-25

Similar Documents

Publication Publication Date Title
CY1121129T1 (en) TOY FGFR4 INHIBITORS
UY34559A (en) BROMODOMINIUM INHIBITORS
UY34515A (en) SUBSTITUTED TRIAZOLOPIRIDINS
UY34374A (en) BENZILINDAZOLES REPLACED
CL2012000590A1 (en) Process to prepare w-transaminase (r) -selective.
UY34765A (en) NEW COMPOUNDS.
UY34502A (en) ARILOS AND BICYCLIC INHIBITORS OF SODIUM CHANNELS
UY34039A (en) FUNGICIDE COMPOUNDS
UY33925A (en) TRICYCLIC QUINASE INHIBITORS
UY34824A (en) NUCLEOSIDES OF URACILO SPYROOXETHANE
UY34034A (en) TRIAZOLOPIRIDINS
UY34632A (en) OXAZOLIDIN- 2- ONA COMPOUNDS AND USES OF THE SAME
UY33978A (en) NEW BICYCLIC PYRIDINONES.
UY34210A (en) COMPOSITIONS, METHODS AND SYSTEMS FOR THE MICROPROPAGATION OF PLANTS
UY34318A (en) ? USEFUL ISOTIAZOLINE DERIVATIVES AS INSECTICIDE COMPOUNDS?
UY34467A (en) PROCEDURE FOR THE PREPARATION OF REPLACED 5-FLUORO-1H-PIRAZOLOPIRIDINAS
ECSP14013251A (en) DERIVATIVES OF 5-FLUOR-4-IMINO-3- (REPLACED) -3,4-DIHYDROPIRIMIDIN-2 (1H) ONA
UY34006A (en) IMIDAZOPIRIDAZINAS
CL2012002082A1 (en) Process for the preparation of lacosamide, by hydroxymethylation; intermediary compounds
UY34329A (en) TRIAZOLOPIRIDINE COMPOUNDS
UY33976A (en) DERIVATIVES OF PIRAZOLO-PYRIMIDINE.
UY34158A (en) HERBICIDE COMPOSITION
UY34553A (en) PERINDOPRILE L-ARGININE SALT PREPARATION PROCEDURE
UY34791A (en) N-ETHYL-4-HYDROXYL-1-METHYL-5- (METHYL (2,3,4,5,6-PENTAHYDROXYHEXYL) AMINO) -2-OXO-N-PHENYL-1,2- DIHYDROQUINOLINE-3-CARBOXAMIDE
UY34038A (en) AROMATIC ESTERS FOR AGROCHEMICAL COMPOSITIONS.

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20211015